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Tandem Mass Spectrometry 
in Newborn Screening 
A Primer for Neonatal and 
Perinatal Nurses 
Saudrn A. Btmta-Wrigbt, MN, RNC, NNP; Robert D. Stei11e1-, M D 
Since I 96 I nt:\\ born screening for t.:rror!t of mctabolbm (E\1) lla!> unpro\-ctl the di.1~o!tb, trt:Oit-
mcnt anti outcome of newboms wil.h an EM Rcccmly. advance'> In laboratory tc'Chnologr with 
tandem rna'~ !tpectromct 'l (M / M ) ha.' incrt.~.t.,ctl the identification of nc'\\ bom~ with an E~l 
With a single tlm:d filter paper hlood !>pOt (Guthrie R, "iw.l A. A ~unplc phcnyla.lanlnc met.hod for 
detecting PKl m large popubtion~ of oe'' bom infan1s. Pt!diatrlcs I %3.:H 338-343). ~I / MS c:tn 
t<.lcmil) more than ~() dbonler; ol metaboU:.m Tim rcv1cw will explon. M!-,1\15 to provide a better 
undcr,tandmg of the dev<:Jopmem .tnd applic.ttion of thi!t tcchnoh,!n to newborn screening for 
perinatal and neonatal nur.es. Key ~ords: enYJI'S of metabolism metabolrc tliseases, neu•born 
screening, tandem mass spectrrmii!IIJ' 
I N 1961 , Or Robc:n Guthrie developed a ~en­·itivc. but ~imple and inexpensive, creen-
ing test for phenylketonuria (PKU). 1 1111:. 
~creening u: ·t used a bacterial inhibition .ts-
f'l:ty of dried blood collected on ft1ter paper 
w mt:a!>ure phcnrla laninc. With early identi-
fic:uicm of newborn~ with PKU, earlier initia-
tion of a diet low in pb) enylalanine resulted in 
normal cognitive development, rather t.han o;e-
vere mental retardation a ·sociatcd wit.h cl:t~si­
cal PKU.1 By 1962, Oregon and Massachu eus 
began crccning e\'ery newborn in those 
'itates for PKl . \ By the late 1960s, the practice 
of rou tine newborn screening for PKU had 
expanded to almo:.t every tate and soon af-
terward to most dneloped countries. Within 
2 decadel>. a.lJ '-tales had instituted univer-
al newborn -.creening for PKU. •-- • ub t:-
qucntJ}', newborn ~reening programs h:we 
added scrcerung te:,ts for olher tlil>orden,, 
including amino acidopatbies. galactosemia, 
congenHal hypothyroidism, and sickle cell dis-
e:u.c. The dil>orders were added based upon 
principles of newborn l>Creening. Before a di'>-
easc b con idered suitable for addition to the 
newborn ·crecning test, it should meet the 
following criteria proposed by Wilson and 
jungner"· 
I It sbouJd be frcquenr and severe enough 
to be a public bealrb cooCl.-ro. 
2. It shouJd cause a documented spectrum 
of symptoms. 
3. The scrc<."ning tc:,t must be reliable, c;im-
ple, and have a low inddence of false-
positive and fube-ocgative rc~;-ulrs. 
 
   
4. The disease ~hould be treatable to a de-
gree to decrease the significant negative 
outcomes, such as death. 
5. The appropriate confarmarory diagno!r 
tic te ts must be readily available. 
6. There must he :m e tablished foUow-up 
program. 
7. There should be a positive cost-benefit 
ratio to society. 
11wse principles emphasize the goals of 
newborn screening.11" 1° Few tests and condi-
tion~. however, will fulliJl all of the e crite-
ria ami the effect of rn:atmeot rna} not be 
known for years after a tc t i introduced. Al-
mo t aU of the disorders screened and iden· 
tified by ncwbom !>creening progmml> arc 
kndclian conditions. llowever, incrt.-asingly 
other condWon:., ·uch a IUV and congenital 
toxoplasmo is, have been included in some 
screening program.,.11 11 For a few of the di!r 
order ·. the evidence for efficacy of early med-
ica.! intervention that earl} screening allowed 
was overwhelming, a!> with PK.U <md con-
genital hypothyroidi m. :u.\ Ll1 other cru es, the 
hcnetit!> of medical intervention are less dr.•-
matic, but are ignifkant enough lO warrant 
screening; an ex:tmple is galactosemia. Early 
identifkarioo of ne, born with cltts!>ical 
gal:.tcto~mia prevent the early death from 
hcpatocc:Uular damage and gram-negative 
sepsis. 11 However, a survey of 350 cases re-
vealed that most pauenL'i with classical galac-
tosemla, even if diagnosed early and treated, 
have lower lQ than expected, peech and 
motor dysfunction, and growth and ovarian 
failure. 1-s The screening prevented mortality, 
but not the long-term sequelae. 
A more disorder!> were added to the orig-
inal !>Cteening for PKU, the laborJtory need!. 
increa ed a!> each di1.ordcr had a separate hac-
terial assay. Screening needed to be more effl-
ciem and comprehen!)ive. The development 
of a ingle as ay sy -tem that could be used 
to detect several disorder · rather than a <>y'r 
tem of separate bacterial assays for each dis-
order was desired. The u:.e of chromatogra-
phy, which provides analy L'i by producing 
band1> of color at different levels on a column, 
rather than bacterial assays was tried. 16•1- P'J-
per chromatography was too sensitive for uti-
lizing to screen newborn blood within the 
farst day of Life when the majority of spec-
imens are collected. Next, thin-layer chro-
macography w•~ explored for screenmg new-
born urine.111 This form of chromatography 
had everal disadvantage -.11' Fir t, the urine 
specimen could not replace blood in detect-
ing either PKl J or congenital hypothyroidism. 
ll1e second issue was the collection of urine 
specimens after dhcharge from the nur cry-
a logistic nightmare for the pan.:nts and the 
healthcm-c: prO\ iders. Third. the concentra-
tion of urine varit=s from being highly con-
centrated and producing f.tlse-po-.ith·e rc ults 
to highly dilute and causing fabe-ncgativc re-
ult . lastly, C\ era I of the dL-.order!> identi-
fied by urine analy~b are benign, such .1s hil>-
tidinemia and llartnup disorder. As a result, 
newborn urine screening based upon chro-
matograph}' h:t!> been discontinued.1'1 nh·er-
sal newborn ~crcening continued to rei} on 
the "one test-one disorder~ sy ·tern Wtth ad-
vances in technology, t:mdem mas:. spectrom-
etry (known as /IIS/M!:I) hru changed universal 
newborn ~creening.zn,l l The use of MS/MS al-
lows for screening of multiple metabolic dis-
orders using a ingle analytical run. With thi 
technology, a numerous array of metaboLic 
di orders. including amino acids dborders, 
fatty acid oxidation disorder.!>, <md organic 
acidemias have been identified during the 
neonatal period many times prior to a catas-
trophi<: event (fable I ):~'>-29 1l1t: purpo ·e of 
this re\·iew on MS/MS is to provide a bet-
ter under tanding of tllis powerful technol-
ogy and wh) ir i important for nuThes to 
understand 
MASS SPECfROMETER 
A tandem mas · pectrometer is a type 
of anal}"ticaJ in:,trument u ·ed in lahoratorie 
known as a mass spectrometer (Fig 1).30 
The mass :,pccrromcter in~;trumcnt was de-
veloped more than 20 years ago.lll.3 l This in-
strument can analyze numerous compounds, 
uch a tho e in body fluids, environmental 
  
Table 1. Summary of disorder detectable through tandem mass pectrometry during the neona-
tal period.* 
Amino acid dlsorders 
A.rgillinemia 
Arginlno:.uccinic Add 
(ASA) l}•asc dcfidency) 









Maple syrt~p disease 
(MSO) 
Fatty acid disorders 
Carnitine/a<.")'lcamitine 
translocase deficiency (CA1) 
carnitine palmilOyl u-.tnsJerca.se 
deficiency, type I (CPT-I) 
C:unitine palmiroyl transferase 
deficiency. type U (CfYf.U) 
Carnjtine trJ.nSpon defec1 
long chain 3-hydroxyacyi-CoA 
deh}'drogenase (!.CHAD) 
deficiency (frifunctional 
protein deficiency (TPF) 





(~WJD or GAll. Glutaric 
addemia, cype II) 
Very long chain acyi-CoA 
dchydrogena e (VLCAD) 
ddklency 
Organlc acid disorders 
2-melbylbucyryi-
C.oAdehydrogcnase ddidency 
(2MBCD or BCAD) 






l}~.tSe deficiency (HMG) 
Glutaric acidemia, type I (GA-l) 
lsovaJc.ric acidern.ia (IVA) 
Malonic acidemia 
Methylmalonic acidem.ias (MMA) 
Mitochondrial acetoaceryi·CoA 
lluolase deficiency (SKAT, BKl~ 
3-ketothiolase defidency, fJ 
ketoth.lolase) 
Multiple carboxylase deficiency 
(MCO) 
Propionic acidemia (PA) 
• Adapted from Millingtnn and Kocberl. 22 Z)'tkovicz cl al, l j and Rashed et al. 2~ 
contaminates of water, foods, and pharmaceu-
ticals . . implistictlly, the mass spectrometer 
weighs molecules (Fig 2). Molecules are ex-
tremely small and cannot be weighed in the 
u rual method on a scale. TI1c mass pectrom-
eter weighs molecules electronically. Evcry 
molecule has a unique mass. For example, d1e 
mass of water is 18. [n addition to identifying 
a compound by its mass, the mass spectrome-
ter determines howmucJ1 of the compound is 
presenr in the material that is being analyzed. 
TI1e be t analogy for dtis i pocket cllange. 
When you grab a handful of coins, you may 
have pennies, dinles, nickels, and quarters. If 
you sort these from tightest to heaviest, dle 
dimes would be dle lighte c whlle the quar-
ters would be the heaviest. The other coins 
would fall between the dime and me quar-
ter . The rna s spectrometer sorts molccuJes 
in much tile same method. 
TANDEM MASS SPECTROMETER 
The t:mdcm mass spectrometer was funhcr 
refmed a decade ago for clinical use by re-
scardler at Duke Univenity in coll~tbomtion 
wid1 tile Nordl Carolina Healdl Depa.n-
ment.20·21 ·32 A tandem mass spectrometer i 
simply 2 mass spectrometers hooked together 
with a special chamber between the 2 instru-
ments (Fig 3).:H Thus, the abbreviation of MS/ 
MS for tandem mass pectrometry (MS -
chamber - MS = MS/MS). After being 
prepped, the sample is injected into the first 
Instrument. \Vhile In the first instrument, 
the:: sample is ionized to produce molecu-
lar ions and the type of molecules present 
are determined based upon mass-to-charge 
(mlz) r-Atio. The ionized molecules arc sorted 
and weighed. Afterward, tile an1ple is sent 
into the coUision cell chamber. Within me 




. - -~ ••. I 
Figure I. T:mdcm mas~ ~pcnromctcr Pcrmi:.:.lon from \Vaters Corporation (MS Technologic~ Centre) 
col thion cell chambcr, Lhc molecular ion 
-;ample is broken imo frJgmcnted piece'>. 
called mw~)'les. "h1d1 an: like piece::. of a 
puak Alter being fragmented, Lhc sample 
i'> pa<,:-.ed into the .,ccond instrument. Within 
the ~ecomJ instmmcnt, quamitic:'> of the 'It:· 
lct.·tcd analrte(!') arc M>rted and weighed 
.tccon.hng 10 their m/z ratio. The peak of each 
1 
'ample ('4~1"'~ •nU r- :- ~.unplc ioni1cd r---- S•mpl< andlyletl ... Sample onn.cd .o\11.\I)'IC> ••I In tern! tn!«"l.:tl f'1'Gth:d 
8 
Figure 2. 1\imphfied !tChcm:uic of the component~ ol a mass 'Pet:trometer 
   
l·moud"'ml'k 
• S.unplc •ooittd • "'""" 1llJ " <t2h«< • 
lont.t.cd ~pic 
hJJCJ UJl(tn m/7 h \ ntenk.-d 
f OIIII 
1 
""'"' ~·<• n l .:.mplo $0->!lal .wl v.coghcJ I~ l>.t"'<l upno mh - .. 
r-.,,,,, 
Figure 3. "oimplificd CIJmponcnt uf a t:tndcm m:l!>~ .. pectromcter. 
anal te IS compared LO imemal ::.ta.ndard 10 
} idd both a qualitative and quantitath e re~uh 
The rel'.ult c u1 be .tnalyzed within minute'> u!>-
ing sophi!.ticated computer progr.tms ro pro-
duce histogrJm., for analysb. TI1e vertical lines 
of the hbtc>gf'Jm idem it) the m:l!)s v.. hilc the 
horizontal axis represe nts the amount. The 
bc'it anal<>b'1' for thU. i a continuation of the 
e:o..amplc with pocket change. After cnrering 
the fir'it in trumem. the coins are sorteu and 
we1ghcd a dimes, pcnnk'>, nickcb, and quar-
ters. ext, the coins pass tltrough the special 
chamber thar further fr..tgment them into the 
components of themselves. Pennie:-. arc bro-
~cn down into copper and .tine whik nickels, 
dimes, and quarters into copper and nickel 
The JnaJytes of copper. nickel. and zinc woukl 
he qualitathdy and quanlitatin:l) reponed, 
rather than the groups of dimes, nickels, pen-
nics, and quarters. ·nu: MS/ MS anal) '>is works 
in much the same wa}. 
TANDEM MASS SP.ECfROI\-lETRY 
AND NEWBORN SCREENING 
ln a newborn's dried filter paper blood poL. 
the MS/ MS typically tc:-.ts tbr amino acid'> and 
acylcarnitine:... Amino acids are the building 
block-. of protdn for muscles, org:u)!,, tissue, 
and blood An amino ac.:id is identified b) an 
abbreviation uf letter'> (Table 2). For exam-
pk the: amino acid, phenylalanine i'> phe An 
dcvared phe is as.,ociated with the disorder 
PKU. Carnitinc IS an .1mmonium compound . 
which has a key wlc in the trdnsponation sys-
tem for fall> in and out of the ntitochondria, 
the cell 's t' nCrg} fuctol] .j5 When a fat is at-
tached to a camitinc, u U. an aqkamiline -16 
An acylcamitme ''identified b) the i.te ofthe 
fat molecule auacheu w iL The c arc catcgo-
rilcd as short, medium, and long-chain :tC} 1-
camitine or are abbreviated as a comhmation 
of lerters and numbers ( fable ~). For exam-
ple, the predominant ~bort-chain 1~11 attached 
to camitine in the org:u1ic ado disorde r of 
metbylmalonic ,1cidemia (1L\1A) is a ~ carbon 
acylc<trnlllnc kno" n a. .. propionyl and is ab-
hre,uted C~ -\~ The \1S/M. can sort, weigh. 
and quantify thb molecule and all the other 
desired acylcarnitint''>. 
AMINO AOD AND ACYLCARNITINE 
PROFD..ES ON THE NEWBORN SCREEN 
In errors of mctaholbm (EM) . :.pecific en-
Z) mes thr1t br<:akdown amino acids or are 
needed in the t:o m l'CSIOO of fat lO cncf1..")' arc 
either signiftcantl) decrea ed or ab~enl. The 
Table 2. Disorder<, :ts!>ociatcd with abnormal amino acid anaJytc lcvd:. from tandem mass spec-
























Possible dbordcr to be considered 
'\rgmincmia 
< itrullinemia, A.."A I) a .. e dcficicncr 
.wm 
llomoq stinuri.l 
Uao;-,ic:.:ll PKl and h} pcrphen) lalanmt>mia \ ':tri.mt-. 
l)'ro.,inemi:t 
\'ote· l.•trulhncm•·• lmllt-arc:~ .uwruno,ucciruc: :K1ll (A''·''') nrhc:ra~ ddicll'nq \.'-A I) a~ c.lcJ1oc:nq :tl'!tlmnu,uc:um< 
aod hJM- dcfim:nq, \I'-D. \taplc ~1rup di~:rsc: 1'1\t , h)pcrphc:n)lal.mulcnu:t 
• \\1.1p1cc.l fn1m \hUinJthmH .tnc.l "<onhwc'l Rcwun.d '\c:\\horn 't<.:rccnin~ Prn~r:un 11 
!>pecilk enqmc i., not able lO metabolize a 
compound. When a compound cannot be mc-
tabolizcll it begin., to accumulate in the bloou 
and ti. .,U<..'l> of the bod). The compound he-
comes toxic anu il> a pobon rarJ1er than ,, nor-
mal bod) sub tance. The M /MS can measure 
the analytcs of peciJic amino adds and aq 1-
carnitines in the dried blood "POt. When ah-
normal rel>ults arc identifi<:d, the metabolic 
!>peci;rlist diM:lls~e~ with the newborn·., pri-
~ care providtr hmv to proceed L<> con-
firm the prc:.encc: of an EM.~ Once -;am pit:~ 
for confu-matorr studie~ arc obta.ineu, treat-
ment rTL1) be started prior to resultS of confir-
matoq studies. which can take days or week.., 
in some case.,, uch as testing fibrobla'>ts for 
carnitine transponer deficiency (CID) w 11 
lt i'> important 10 note lhat \1. /MS cannot 
replace current program-. for the screening for 
the E.\1 tho;order., ofbrotinillase deficienq and 
galactosemia. These mct:rbolic disorders can-
not he identified b) M~/MS at rhis time and 
mu r be detected hy other mctholls such a<; 
fluorometric anal}~is.'1 · 1 ~ 
DIAGNOSIS OF AMINO ACID 
DISORDERS BY MS/ M 
Disorders of amino acid metaboli"m were 
some of the earlieM EM investigated on a 
large scale.• Thh was due to the a\ai.Jabil-
it) of laboratof) technique<, to <tepar:ue and 
identifv amino .tci<h in bod} fluids ln 1961. 
the de\ clopmcnt of a bacterial inhibition .t:,-
Sll) for phen) laJanine meru.ured from whole 
blood resulted in a rcliahlc spccifi<: -.creen-
ing measure to identify newborn" wrth PKU 
(Box L) 1 The serum phcnylaJanine lluoromct-
ric proet:dure wa!> modified to he a reliable 
crcening te'>t ~ 1 The fir t report of ~1. /~1 
in the .uuly'>J' of amino acid anaJ} b was 
in 1991.~2 Thi~ w,L., followed b) the use of 
M~/M~ pecifically to screen for PKL lt. In 
the initial research report of amino .reid anal-
)'Sb for PKU with 'VtS/MS, ne"vborn blood 
~pot -;amplt:s ""'ere obtained from normal in· 
fantS. infanu. with confirmed PKU and intant'> 
with l":lhe-posith e rcsultl>, that is tho'>c infant..., 
who screened po-.ilivc, but in ·whom PK( 1 was 
excluded to confirm th~: utihry of \1~/MS. zc, 
'l11e concentration'> of phenylalanine and t) -
rosine from MS/MS screening were compared 
to lhc conccntrauons ohtaincd from lluo-
rometic methou . The re ult.-; were compara-
ble. A ~ub ·equem MUd) examined the inter-
pretation of phcn} !alanine level~ obtained in 
newborn filter paper -;pot ample!> collected 
at le s than 24 hours of age comparing MS/M 
and fluorometric analysis. ~; All newborns 
with confimtcll classical PKU :md variant 
    
Table 3- Disorders a sociatcd with abnormal carnitinc and acylcamitine anaJyte levch from 
tandem m~s pecLiometf) during tJ1c: neonatal period• 
Name of 
Change 
AnaJytc acyl cam ltine T Possible disorder to be con.o;idcred 
(.() C:trniunc: ( total) X C. PIT 
>. CTD 
(2 Ace!) I X <.arnltine Tr.m!>portcr Defect or Insufficicnq 
( ~ Propioml X \1~. PA. \1CD 
C3·1>C \lalun~ I ). \lalonic Aciduria 
( I But)q l >. S( .AD ddictcnq van.mt ~CAl) deficit:nq. 
l ~hULyr) I..CoA dchdrogcna~ dt:ficicnq MAD 
< 1-D \Jcthylm.llon) I X \IMA 
('; btw.tlc q I X 1\'A 1-mclll) lbut ~ r)I·Coo\ dehydrogenase: 
ddicienq. MAD 
C'i·DC (,luLJr}l X <•A·I \ lAD 
C"i-011 S.llydro )'i'>OYalt:ryl X ;PM C •. \-methvlglmaconyl CoA hydrata.'-1: 
ucficicnq, IJ\1(...<.o.\ I~-<. MCD, 2-mcthyl-3011 
butryl Co,\ dchyurogcn:J-< 
C'l I figlyl X 3M<< 2-meth) I :H>hhuh I') I < oA d<:h)·drogena .. c:. 
~MT. 3-0.xothtt~la,c ucll<..tt:nq· 
(.() I lc'anO)'I ;.. \1CAD. MAD 
<.a Ouan1>)'l \."X \I CAD 
CIO D<:<..":lllO) I X \I<.AD 
(:I(): I Dcc:c:no)l ;.. \I CAl) 
(.11 J)ockc.::tnoyl X ,\lAD 
( I I Tclr.tdc<..":lrlCl) I X VlL\ D 
(.t 1. 1 Tctradccc:nu) I X \'I.(..AD 
(.J.Il Tetr:tdoc..kc:cnoyl X VL<.AD 
( 16 l"almitu) I X VL< AD. LCH.AD. < JYnt, CAT MAD 
X CJYil 
C 16-0H -\-11\·droxy pal miLO) I X 1.( IIAD TFP 
CJ8 Oc.:t:tdtcanoyl X VI.(.Al) 
( 18 1 IJnoh:O) I ;.. VLCAD. Plll , (AJ: I.UIAD, ~L\1) 
;.. <..Pn 
C l 8 1·011 3-Hydro"} hnolco) I X LCIIAD, TFP 
\ore· ~\!Ct. dt'n<llt:~> 3·mcthrluuton) t-<:oA carbo,yla-.e dc11c.:lcnq <.AT, t.arnilim:/.K)kilmitinc tran~IO<.~~ ddktcnc-y; 
(.P'Jl , camliJOC palmil•l)'l lr.lll,fc.Tdl\e I tlclictCOC) ; CJYrti t.-:tmillm· p:tlmilu) I trun,fcra-..: 1J dc1lC1CJ1C} , CTI) t.-:~ml· 
I JOt' lr:lll..\poncr dcl1dcnt.y 11\1(.-CuA 1)-J.O.e ~h) dro'C) ·3 mclh! lglut.tn 1-CoA I) a~ lft'lil'lenq· IVA, bcw:llc.:rit. .Kt<lemia, 
1(.11•\0, lull!( cham I ·3·h) dnn .. yaC) I (.OA c.kh)·dm.:cna-.c.• ddictenq \1AD. multiple.• .1q I ( :u.\ dchyc..lm~:cna.'e dcfidenq 
(a!"• knu" o :15 (,.A II glutllru: acidemia, IJ'Pt. II and cth) lmalnnic·adipic ac•duria): \ICAil medium ch;tin .u:y l CoA deh) 
dn~gcna-c ddktcnq \1<.0. mulliple c-arbo~1la-.c dd1ctcnt.') \1 \ t-\.. mc.:llt} lnulontc.: aclc.kmt;~ ; PA. prop1umc acidemu . 
.,CAD ~hurt chain aql ( .nA dch\dru~cnasc dd'klc."fU.:\ l-1<...\1: trul<Khomlrial at:ciiMnl)l-<.uA thiola-.c dctiucnq (al'>ll 
l..nown ,~., OKT. :H.cwtluola'>C.' dcfictcnq, p kc.·tuthtoi.L...:), 1TP tnfunt:"'t tnn.ll prutdn ddictcnq \ L(Af), \t:n lun~: cham 
.tq 1 CoA dch) dm~cn.~ dt•fic.:h:nq. 
Addpll:tl rrom Millington H and 'lnnhv.e>l Rt:·gmnal Ncwbc.>ro '>cn:c:nmg Program ~· 
       
Box 1. 
Ilyp crpbenylalanincmja, PhenylaJan I nerrua. Phc nylketonuria-Alrer native 
Names fo r PKU 
The moM common dhordc:r of amino acu.J ml·t.thoh'm l~ hypcrphcn) lal.tnmcmia, abo known a.., 
pbenylalmtlnC'mia or fJ/Jenylkelonuria CPK\) The mcldcncc ofPKl j, .tppro}..imatcl) 1/IC).(XJO 
to l/2:;.ooo h\ c: h1rth., .... 1l1e disorder OClUf' mon: frequently in pl·oplc: of Iri~h dclocc:nt than m 
mhercthnic ~n>Up!> 1\ PK\1 i~ :m auw ... onul rcct:.,M\t: dJ!>ordc:r. nu: mc:t<Jholic hlock 111 Pll..l i..,m 
the: mctaboh.,m ol pht:n} latu1ine Pht:ll) lal:mmc cannot be ccmwnc:c.J to I) ro~inc: m PKl ' 
(Fig 1). 11' I he: C:ll"} me:, pht·nylalanlne h)'dnn.yla'"' h ah-.ent or '>•gnifk;Uldy decreasell Ex<.:c:..'> 
phc:nyla.Janmc: ao.:umulatc.-. in the: hluod and bo<.h lluid.-.. Tlw kq to 'ul·u :,,fultrc:aunc:nt of PKl 
ha' been e:trl~ di.JltllO'b \\ llh Jit"tar) re-.triC11011 or phc:n) Jal,tniOC ll1 I he: <.bet 2 The dict,lr) 
rl''tri<.:uon of phc:nyla lanme re'>ults m a drop in the conccmrJtrnn of phcnrl.tLuune lc:"-cb and 
the to}.!c mct<thohlt''> llbappe:tr from l)(x!) nllld!>. A' a rc:...ult frequent quantitati\ e •t.'>:.c<,,mcnt of 
the conccmraliun of phc:n) lal.minc m the hluoll " needed for monnoring. The lcn:b 
rc<:ummcn<..lcd ·" at·cqHable for pbcn) lal:u1111e h:1vc \<trieu fmm I ROw 900 11 moi/L. lltm l'\ er <1 
u~htcr r.mge hctwcen llU and -\{)0 J,Jmul/1 .,howed a hnear relationship ))(·tween IQ .mc.J mean 
concentration ovcr ~00 ftnml/1.. 1" The dlfft:rcnec: wn:o clear when phcnyl:tlanme level' cxct•cded 
ROO JIOlOI/1 that I(..! wa' ncgnti\•cl) impat·ted The: :b,l!>tance of a d tctitJ:lll "ith experic:ntc: in 
managing I'Kt 1 vttal Treatment TelJUtrc' the lifc:l()ng rc:Liuclion of excc:.,~ivcl~ elc\'atcd 
phc:nylal.mine lc\ eb lO a!> normal a:. po.,.,ihlt- 1 ~ There: arc no\\ m.m) low·prmein food~ •" .tilahlc 
tlut arc: lm" in phc:n) lalanmc: Phcn) lal.mmc low-pmtein :.uiNitutc: food, fadlltJtc impnwed 
long-term compliance wnb phenylalanine Tl' \ltKllon wtllun lhc thcrJp\ range. Oc~pm: lhi-. 
lifc:long thc:mpy, puhhc poUq ha:o not addrc,:.cc.J the: em cragc: of mc:di<.:al f()(J<h and be\ crnge:.. 
Thc:-.c: fi>ud!> an: htbclcd for medical :.upcn Il-ion and not typicall} .n ailabk U\-t:Nht:·<.·ountc:r :11 
thl· local grolt'r) 'LUre due to the r:trity ol the .. c: (.'()llc.Jjtilln!>. Man} ~l.ll~~ hav"' pa..,~>ed lc:gt'latiOn 
that mandate~ ~mcragc: ol medical fi10ch ami hc:\eragc~ for the treatment of El'\llt, :.u<.h a:. PKI 11' 
The market for thc~c food~ arc lunitc:d ;md mn plate .1 :oi~mJka111 burden ut the f..1mil) a~ m;un 
nf the m:IJor in,ur.tnte providef' "'IIJ not Ul\'l r rnc:dicaJ ftxKb and he\ l·r.tgc~ inclullini-t 
phc:nylalaninc·frt:t' lurmu!J nccdcd b~ tht newborn.'" Tht' n·:Nm for the: h.:gi-.13tivc mandatt 
~' ·'' data clcarh mtl•catlllA that :m) devi:ttiun from a lifc1>t) le of pht:Jl\'ttwnmc re:.lriction will 
ad,.c:r:.el) impact ncumphy~it)logit fun<:tion J.n<.l brain mydsnatiun ll1c rc~ult 1!. lower IQ and 
im:rc:al-ed heha,·ioral pn>hlcms. •~ 'q ~~~ The '"'lilA' 1n the M.ll<: w louppon phc:nylalanmc: 
re .. tnction i~ the: long·tc:rm outcome of mcrca~d normal intcllig(·ncc and heha\oior. Thu~ the 
person" ith PKt i:. an anivc: mcmbc:r of '>ll<..ll't)'. ratht'r than dt'[ll'nuem upon 1-uppon due w 
lad. of appn>prullt nutriliona.J lht:r.lp} Prt: \C:nli\•t: mcdidnc Jn the form or lllL'ilicallclOd~ ;md 
h<.."\-<..:r:tgc:. lalktng phl'n)lalanine is the kc} 
forms of hypcrphcn} lalminemia, uch as 
newborns wilh an inc!"l"a.sed phcnyl:tlantnc 
lcvt:l but not elevated enough to reqt~~re mc<.l 
ical nutritional thcrap} were idcnufied. In 
addition the use of \iS/MS decn.·a ... c<.J the 
number of fubc-posnivcs from 91 to .. ~. Fur-
ther analysis of the data using phcnylala-
nine/ryrosine rauo ( <2.5) reduced the num-
ber of fal-,e-positivcs to I. Figure 5 illu..•itmtc:. 
t.he:: hJStOWdl11 from MS/MS profiles: one from 
a normal newoom screen and the other from 
a m .whorn with confirmed PKll. "iincc theM: 
early studit:s with PKU. MS/MS hru. b<:m tu.cd 
for analysis of other ammo acid<> lO tocn-
tify other disorol' r'i of amino acid metabolism 
(fa hie I ). 29 "'·1 c;-; 
DIAGNOSIS OF FATlY ACID 
OXIDATION Df..FECfS BY MS/MS 
Disordcn. of fall} add oxidauon compro-







"'"'"' ~~.·h•• hcnn· lh< d.i"tcal nom.:. • Pt.. l l' 1 
0 A 'UIIIUIJIC< ID UlllrC~Il:d tnl.oniJ. Mlh l'k.l 
Fi&>urc '' · Sm1ph.fitu patllw:t) ut ph~.::nylalanine metaholi~m in h) pt:rphcnrl.lianmc..:mi~ (l>Kll) PKl b the 
rc~ult of a dl'fen 111 the cnz} m1.. phcnrLalaninc (PI tl:) h) droxyl:l<te ( P·\11) \"l'tich b respon~lble fur com crt 
Ulg phc11ylalanfnc: (phc:), .111 t:~c..:ml:tl :tmino acil.l. w t} rosim· rn R>. nom1.11l) a noneo;.-.t·ntial amino acid In 
cl:t"-'icll PKI J there" a l.lc:fcct in PAll ac:tivity rcsulung in an ;~ctumul:uion uf Pllt in the blood and bod) 
lt'sucs whilt fYR OM) he: deficient Thu:., ·n R hc<..omc:~ an t''":ntt.tl ammo aUd for newborn' vmh PKl 
lctr:th)drob•optt·m (II, hu1ptcriJ1) ''a cofactor cnryme lor J>AII II, hioptcrin <.lclkienq i'> another r:m: 
ctu'>t' of P'-.'1 
of EM '\s carl) as L9H 1, Lht: diagno tic valm of 
a.nal ., • ., of aq lcarn1llllC · wa_' demun•.trnled -II• 
1\Jmo't •• dc..:<.ac.Je J.tLcr. the f<.."a:,ibility of u'i-
mg MV\1~ for -.crccning blood or pfiL<;ma 
for me<.lium-<:hatn aq 1-CoA dehydrogenase 
(M<..AD) ddkienq, the mo~t common db-
orc.Jcr or fall)' acid oxidation. was cxplorec.J 
(Box 2) 2" The initial c.Jiagno is of MCAD dc.O-
<.'It:ney wa..-. eMabllshcd by ;~cylcarnilinc: anal-
ysh a!> an elevated CB (oclillloykam.itinc) 
concentration and a ratio of C8/C I 0 A£Calcr 
than 4 ro 1. ·nw...c same criteria were ;tp-
plicd to a :-.mall ..ct uf neonataJ biOO<l spot.., 
rc:tric.,.·ed from sLor.Lgc and successfully ap-
plied A suhS<.'qucnt st\tc.Jy v<. ri!kc.J the use of 
nt·whom dric:d blood spot!. from newborns 
with confirmt·d MCAD dcficicm:y anc.J healthy 
ncwhoms.""' In a prusp<.:ctive stuJy • .MS/MS n:· 
\eakd dt·\atc:d CH k\cb in I) infants 611 The 
c.Jiagnosl'> of ~IC \D deficiency v.t1., conJirmcd 
m a.ll 9 ca ... c-. figure~ illu rratcs the hhwgrnm 
Jrom M~/\1.., protilcs one from a nonnal new-
horn screen and the other from a newborn 
\\ itll <..on firmed M<.AD c.Jeficicm.·y. MS/MS lUL'> 
Jx-c..·n used for an.tlys~ of aqkarrutine!> for 
oLhcr fatty acid oxid.umn during thc newborn 
pcrtud (l':lble I ).h'l "'1 
DL<\GNOSIS OF ORGANIC ACIDEMIAS 
8\ MS/ MS 
The organic add EM are c.Jbonlers tJ1at less 
than 20 yt.-.us ago were perplexing to un-
d~r.o.ta.nd. Phy'>iologK-aJiy man) of Lhtse dis-
orc.Jcrs liharc lht: <;arne catabolic pathway:, 
      
Normal vs PKU 
100 Normal 
d4-Aia 







140 160 180 200 220 240 260 280 
Figure 5. Aminu Acid profile Aener:uell h) MV.\1~ of norm.tl bhlod (uppc:r) compared w1th that of a 
newborn '' uh h) p<.:rphc:n) lalaninem1a (lowc:r) Permb~ton from W:1tcr' < :orpor:uion ( ;\J<., Tc:thnolo~ic:. 
C..t>ntre) 
Box2. 
Medium Chain Acyi-C.oenzyme A Deh ydrogenase (MCAD) Delkicncy-More 
Common Titan PKl,; 
Tilt> mo~t c·ummon di.,nrdc:r of 1:my add uxidauon i' medium chain ~C) I..CoA dehp.Jrogena~c: 
(M<..AJ.)) delicu:nqt.~ 11lt: incidence of ·t\.AD is approxlm:uclr eMimated at 1/6000 tu 1/10.000 
Cauc;lsi:m binh~. making 1CAD the most common F ..M dhordc:r. \ICAD llelicienq i~ .111 
auw.,omaJ recessive llbordcr :md i., char:K"tcrized h) cpl:-.<ldic tllnc.., , ..uch :1s vomitung .md 
leth:tf'A} a"ochncd wtth potential I} fut.tl h) poglrccmia. Mt:tabolic dccompcn:.Jtiun occur'> after 
~ting or catabolk .,trc :., ... uch as a fc\cr. M<.AD ddkicnq h a~~ociatl.:'d witll ~udden 
unc..'l.pt:cteu ut.-;uh in mfanq and after ~uch minimJI !!.lre"c' a., pour or dJilllhood 
immunw1tiom '>'-I•ZThc enzyme, M<.:.AD h onc of the mhod1ondrial aq I CoA dehydrngc·na,c.::. 
Ulat Jfc needed to Ut..11) 1e the iniua.l Mt:p'> in the beta-oxtd:nion ol fatty .tcid'i (fig 6) £;1eh of tht> 
c!lZ)me.., 9. ithm the hl:t.H>"'..id.ttion :.par:tl Is 'pccifk for on I) cenain fall) J<.:td cham length" 
\IC.\0 accept~ full} ,aq 1-CoAoo; withm length of 6 to llca.rhom. TI1c mctJholic.: hlock in \!CAD 
dctkaenq re .. ui L~ in the mabtlitr to oxtdu.e fatty acad., to produce energy 111 Treatment b .,impl~ 
the avoillam;c of fasting and the.: provt:-.1on of caloric ~up port during time' of ~m.- s, such .1:. 
childhood immunization<, Supplementation with carnatinc ,., contro,er.,ial. Initial studic' wtth 
oral carnatine .,upplemcnt.uion reporreu .111 increa-.c in the conjugation and .. uh,cqucnt urinary 
e"\crctn>n of J.C)I group~ lw.M As a re!!>ult. there w~L' an mcrc~c in the :t\ aal:!bilit:) of free CoA and 
dec.:rca..,cd ac')I-Co. \ accumulatton u1 1 ht' mttochonllri.a. llo" ever, a '>Uh:.equcnt >tUd) rc' c;Lied 
finding~ that cru.t doubt on the ,-JJuc of long·term trcaUllcnl \\-ilh c:armune 111 patient' with 
MCAD.1.c' The supplementation of carnitinc inhibited glycmc conJugation. which is the tn;ljor 
patJ1wa} for the di.o.po al of C6 to C8 aqkarnitinc anal} te'>. u randomiLcd, duuble·hlinu ~tUU)' 
ha., bct:n <.lone to ;mswt.T the que!>tion if ~upplcmemauon with camitlnc '' needeu Ill parknr' 
with MCAD. 
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' 3 Hyllroxyat:yl-C'oA 
:-;AD 
3 llyllroxylacyi-Cot\ d~hydrogena..c 
' 
.'-Kctoacyl· Co A 
l )1 ~ ~ . 1-Kctoru:'. 1-C'oA thiolu\C 
Acrtyi-CoA 
Sttc of main 1!1\J"}"rnc defect 
Figure 6. Simplilkc.J p:tthwa of medtum ch~tin ac) I..CoA c.ldl)dmgcn:u.t· (\I( \1)) deficiency "vithin lhc 
hrta oxidauon ~ptral of fauy ;Ktd!> 
as the br.lllched-chain amino acids. TI1e stte 
of rJ1e eruymatic defect, however. is suffi-
cicml}' removed from the step where the 
:unino group is lo t and does not accumu-
late. A."i a result, in the labordtOf}. the u:-ual 
amino acid chromatographic anaJr-.i'> doe not 
work for the itknlification of dbordcrs of 
organic acid metabolism. With the develop-
ment of gas chromaLOgraphy-mass spectrom-
etry, the unique metabolite of the error of 
organic acid metaboli"im were identified "" 2 
It wa.s an unw.ua.l odor of ~sweat} feet• or 
" locker room odor" that wa.s recognized b} 2 
chemiMs a lhat of a volatile short-chain or-
ganic add. Subsequently, i ovaleric acid was 
the fir t organic acidcnti:t to be validated by 
gal'> chromatogmph} -i Acylcarnitine profile 
of isovalcf) I wa.s determined from urine. \l 
Thb led co the acylt.mnitine profiling of iso-
\"alcric acidemia (IVA) (rom newborn blood 
polS (Box 3).21 On M "/MS. fVA i considereu 
when there i an elcv~ttcd CS, isovaJeryt.:H An 
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Figure 7. i\q lcarnitmc prolilc gcnc.:ratcd b) \IVM'\ of normal blood (upper) compan:ll "ith that ul a 
nc\\ born with mediUm chain aql C:oA dc:hydrogcnJ!>c (~1( AD) d<:licicnc' (lower) Pt·rmis.."on from \Vater. 
Corpor..1tion (M.., Tcchnologk., <.cmrc) 
elevated c; that h t\\ ice the normal cutoff 
value .,hould rcct'ive prompt follow-up to the 
primal") care physician of 1 hat infant. Fig~ure 9 
illustrJte., the hbtogmm from f-1S/MS profile!>: 
one from a normnJ ne\'. born screen and the 
other lrom ,, newborn with conftrntt:d IVA 
MS/MS ha., been u~ed for analysis of aq lcar-
nitinc for otht-r organtc aciucmias during the 
newborn period (1able l ). b9 ~~~ 
IS UES WITH MS/ MS 
More and more newborn screeniJ1g pro-
gram · aero:-:- the l. 'nited ~tate · and the world 
are adding MS/MS methodology to new born 
~>crecning. ·n,c "one 1c::-.t-one di1.order" i!p-
proach limtted thc number of di~order~ that 
could be ~cn.:ened . l)•picaJI} . only 3 ro - dis-
ordcrl> would lx· crecncd uepemlcnt upon 
the:: :.Latc.9 1 llowcvcr, with d1c devdopmcm 
of M f\1S for 1he anaJy~is of dried newborn 
blood spm~ for E,\1, w ting lu:. become more 
of a · one te'>t-man} disorder~.· l~/MS h:.t'i the 
c-Jpabilit) of detecting between 20 and 40 
di order., depcndem upon the analyte:-. be-
ing measured '\ ith increa ed e..-xperience. the 
number of dborder~ have incrcao;ed- wilh 
thl· hope: thar morbidity, mortaHty. and mental 
rewrdation will he decreased llowevcr. the 
natural hbtor) of m<Ln) of thel>c disorder are 
unknown a~ the) have nm been identified un-
til recl'ntly in the neonatal period. In addilion, 
nut all of the dborc.kr-. hnve been idenrtlied 
in nc'" bornl> a ... '>omc EM <.li'>orders ma) not 
have diagno tic analrte proem in the early 
neonatal period.'H Man~ of the:: E.\ls have been 
identified in older cbildren-thu facilitating 
care LO he ba~cd upon diagnosis rather rhan 
'iymptoms and :.a\ ing' in treatment co'its lllli 
is hoped to be one of the major bcnefib ol 
MS/MS-l~.trt} diagnosb of E I disorder., that 
will decrea~c the medical cost~ during the fir.,t 
S } ea~ of life 
With the automation of MS/MS, high· 
voluml· MVM!:l -.crcening for amino acids, 
full} acid <>Aidation. and organic acill tf•.,or-
dcr-; became a reaJit) by the mid-1990s. The 
initial n:portl> of usc of MS/MS in univcr~al 
newborn l>Creening demon~>tmtcd iL., usc 
iJ1 large- cale newborn . crecning program~. 
:.uch a., the 'lorth Carolma Newborn ~creen­
ing Program, the New England 1 cwborn 
  
Uox 3. 
Isovaleric AcJdcmia-Qne of the Most Common Organic Acideml~ 
in the Neonatal Period 
In 1he ~ick ne\\ horn, mt'l>tbohc :tcido~•~ '" .1 common finding In '>nme c-.L'-C,, the melaholic 
acidow, i~ :tcutt:. ~t·,cre and hfe thn:atcnmg \Vhile in other c:L'-C'> tJw ::Kido!>i!> is rntld bUI 
pcr'>t'>tcnt. and m ~till other-., it rna) be inu:rrnittc::nt Common trc:atntcot of mcmbolk at:id(l'>t'> ln 
neonate' tl' tllc admmhtratmn of h1c:trbonatc Almo~t withoUI c'cepunn f\1 prc,cnring aclllcl} 
tn the: nc:unatal period with metabolic .tcidll'>i'> will not rc:'pond to hicarbon:ne. C:'I:Cl:pt 
lran, tcnll) lllt c flcc1i\ c lrc:ttmem of acido:.h 111 EM b correction uf the eau~e of 1he addO!>i!>, 
'U<.:h .L'> decre • ..,ing the endogcnuu~ ovcrpmducuon of 'pcciJk aud~. 
rhc.: htrgcM c:ncg1>rY of E,\1 a'>MKiau:d \\ lth mclaholiL actdo~i~ durmg 1he nc.:unataJ period b 
org.m k audcmla:. ~,--b IMn-alcri<: .tcid<:mia ( IVA) ~ 1 of the 3 common organiL acidemias to be 
c.:t~n'>idered m th~: C\-:tlualton of metabolic acido~h \\ ith .m incrt-:.tsed iun A·•P ( > 16) in the 
m:whurn "'- IVA w:t.'> fir'>t reponed m J 96(, .,. -.,. 1\ \ '' ••n :Juto"unal n:t.·t.·~~i\ c condtuun. The 
mct:Jbolic hlod, in 1\'A i ~ the.: re~ult of dekcuve hmnchctl t·ham .tmmo :totlmetabuh~m. 
affecting the cataholhm of hnlcuclnc (Ut:) The mokcular hlocJ.. 'llt."dficotll) m IVAi' i.n the 
enz) me bovaltf") I CoA tlch} drugcn.!'>e (rtg H)*' 1l1c typical prc,entatton in IYt\ t!> a prc:viousl} 
health~ ne" born at birth "ho r.tpttll) hccome~ til af1er the fir~t JC\\ d;.ty' of lifi: UtniL-a.J 'i!-!n' 
:md ') mptom~ include l..cwacidu:.h, poor feeding. n1rniting. dchydrniJon. h}pmnni.t, lethargy, 
tachvpnca/hypt.•nrx-a. '-Ct7un: .... coma and .m w.ua.l odor frcqut'ntl) <k,niht:d a.' . ,,'<:aty kt:t" or 
"lod.cr roum u<.lor 
I 'he rn:magemem ul a nt.-wborn "' ith :t pre!>umcd di:tgnn~•:. of an organic .Ktdemi:l , c.,pec.. i:tll) IVA. 
b w lir'>t '>tabiluc the nc:\\ horn \\ ttlun 2 1 to 1H hour'>. the re,uJt' t~f quantilati\'e blood amino 
add (Qll \A). urine Ol'g:llll(; acid (l ( )t\), and pl.l!>ma .IC\ lcantililll pmftle ,tn;tly~t' ~hould ht• 
available If the lahor:llof"} cannot prmide rc!>ult'> in thi-, time fr:tmc a.ltern.llin• arr:mgcmem~ 
wllh another lahoratory , 110uld he pur-.uctl l11t: l OA will be diaWlO'-liC.: ll1r 1\'i\ with the 
prc.,t:nn: of l!>ll\ a len lgl) dn~: anti '\-hHimM '",' .tlt.•nt.· acid whtlt. the pl;t..,nu aq k:.rnitmc: profile 
\\ill t.lcmonstr"Jlc ;Jn c:le\:111011 of C'i. t.'lmall."ryl HI ·•n Tn.-.ttment at thi' Ullll i.., dirntc:t.l WVI-:trd the 
remmal tllthe at.:<..urnulaltng m<:·taholitc!> . .,uch a~ ammonia or ur~anic :lt.uJ intermediate:.,\\ ith 
hc.:moJi.th ·~ 10 ' If a center,.., unahlc to pn}\ idl hc.:mntlt.tl\ :.b tn a nt·wbum 1J1e nc:\\ hom :.hould 
be tran .. ferrcd h :changc: tr-an!>fu.,aon .... pcritunc.:al di•tl} "' or lll'mofilt rauun arc lc'' elfidc:nt 
than hcmodialy:>i ' m man:t)ttng the,t· Ui'>nnler ... 11' Jn.,ulln <:an bt u'c:i.l to augmem I he: :mah(llic 
:.tate.:"'' LtrnHinc h uM:d to rc:mO\t to:-.K metabc>litt:' dunn~ lht acute ph:t'e ~<"-~~'• J.)uring :111 
.1cute illne:..,, intr:l\enc>u' t.trniliJlc ,., prcfl-rn·d mer cmtl ;!dmmt..,tr:.uion \he r the nc:\\ born ha' 
been ~tahill:1cd oral fct•dmg' ,J1ould be rl'tnlllat~:d . A ,c:Jcct r:tng<: of ~pcc.:ialt} formula., arc: 
~1\all.thk that l't''tnct cen.tin ammo ackb durin~ the ncunat.tl pt:rioc.l '~' \' "'tth Ph.L , r Aha 
l ifc:lt~ng dtet of prmcm rc.:'trict.ion ·nH: ,.._.,_""' ·tnn: of .t dictiu.m '' tlh ell.pc.:nenc.:e m managin~ 1:~1 
" \ nal l·rc:qlll:nt gro"' th munimring b nec<.kd to .tdlll'>l the nmriut~nallht.·r.tp) plan nlt: 
... uct·c:s .. an the .tcutc management IVA ha:. led HI imprmc:d :.urvival und out<.'(Hnt: The long-term 
progno''" of l\ \'aries dut: w gc..·nc:tic hcremK<:nem. hut '' gc:nt:r.tU~ ext.:dlcnt VI hl·n dt:tgno~l·i.l 
and tn::.ued e.trh 
'tueening Program. ami in \ustralta, \\ hcrl' 
the tcchnolog} wa.., cmbrat:ctL·B.~u.'H Thc!>.C 
prog.ram ... although -.ucLC'>'-ful. al-.o emph.t-
'>1/.C '><>me ot the cluUengt''> with the UM. of 
M!'!/ M • .'' ' 'Pi Thc:~c challenge!> incfu(k the c:r 
tahlishmcnt of cutoff-. lor the ;mal~ lC.'> to m•n· 
imit.c the falsc-OL'g<tlin:s \\ithout an cXCL">'>h c 
amount uf tahe-pu-.JtJVC'>, the: difficult) '' ith 
definitive dta~no'>b lor the newborn with an 
ahnorm:U " : rcen. and the incrca-.ed numhcr 
nf nc:\\ born'> tdenttlit:d with an E.\1 \\ hich 
mtL'-t he fol l1med up Another challenge is 
that of the dtfferent ne" horn popul.tuon<;: 
health), prt·m.trurt or Jm, birth weight , :tnu 
    
Dtct.ary Protem fi · / ':'"'"" 
.IJ. ' 
L · l.CUCiflC 
hm,tlcryl CuA dt.:hvtlrogcna::.c 
0 ' 3-Mclhyklol011) 1 CuA 
... 
1-Jiydroxl' ovalcnc Actd* 
' I ~o' al..:l') lglycmc* 
C Sttc of cn1ymc defect 
• lncrca\cllm UOA in IVA 
Fit.rurc 8. ~implifinl p;llll\\ .1) ot hovalcryl < .nA dchydrogcna'>~.:. th~.: .,itc of the molctular defect in i!>O\":llcrtc 
adtkmia (1\A> lOA tmlinttc:- urine orgamt: aciu::. 
vcq lo\\ birth wt:ight AJ.,o. there is the need 
fur con'>tdcration of to taJ pafl·ntcral nutrition 
with •tnd without carnitine ~upplemenwuun · 
Rnd collection time ... at ks..., rhan 2-t hour ... of 
birth, lt w -1H hour" :tftn hirth, more than -JH 
hour., but lc" than - da} . more than - day ... 
but lc:. than I 1 day-. . .tnd more I han 1 ~ Oa) s of 
age Another challenge 1., that blood concen-
trauon of o:rtain anal} te., change over ttmc 
One of the fnL.,tr:tllons with MS/MS ;., the 
lack of .,pccilicit} of certain :m<LI}'tcs. n ~;:., . 
ample is incrtt'icd C :\ (propionykarnitinc). 
11lc differential diagno:-.i., of Jn clcnut:tl C.~ in 
c.ludc., prupion}l·CoA carbox) la~c de::ficienc). 
alo;o 1-..nown :h proprionic acidemia (P:\ ), 
met h) I malonyl-<(),\ muta~c ut:licienq . abo 
lillown ,,., melltylmalonic acidemia ( \1.\lA) 
.,CVCr:tl CObal;Ulllll dbonJt:r.,, and dietary Yita· 
mm B1! deficiency rhu.,. '>pe::cilk h•nchcm-
ical tc.,h arc ncnlc:d that man) tim<:!> .m.· 
avttil.thlc onh :11 larg~: . • l<:ademk teaching 
in'>lillrtion~> . lhc coordination of the new-
born ~crccnin~ program v. ith fa .... t JaboralOf} 
turnaround time rapid intervention b) the 
metabolic ~pee iali t , the abilit) of the primar) 
care pn)\'iucr to locarc the famil) to a ... ~c.,., the 
nc" born and obtain rcqu ·,ted s:unpk,. and 
tht· conftrmatoq .,.tmplt:s getting to rhe lab~ 
r-.Hoq in .t 1 imcl) f:l!>hion lor analy'>h i-. , ·iraJ 
SUMMARY 
\\ irh thh exciting u:chnology, MS/M~ has 
tncrca~cdthc st·opc of newborn screening h<:· 
yond the ··one te.,t-nnc di.,ordcr" ~stem With 
\1~/ tr..,. nm onl} c:an <.11 ordc:r. of amino acid 
met:tbolhm be identilied but dbonlcr., of 
l~tll' add oxid,ttion and organic acidemia-. can 
abl) be rapid!) adcmi.fied with a drieu ne\\ · 
burn blood -.pot on 111ter paper Theorcticall}. 
orh<.r l:.\1 r.J•:-.ordcr., could be deteued in the 
ne'' born pt•riod U!>ing ~lV.\b . Tht:~e lun: } et 
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Figure 9. Aq karnnlne profile: gcnc::ratcd b) M~/\1~ of norm.tl hloml (upper) compared ""ilh thm uf a 
nt:\"\ b<>rn \\lth ll>m':tlcril acidemia (IVA) (lower) Permh . .,iun fmm Water., Corporation (MS Tcchn<>IOHiC., 
<.ent re). 
to be ic..knl ificd. II b po~!>ihle that some EM 
dhorder., ma} not. have diagnostic anal) te!> 
prc\ent in the earl~ newborn period Stud-
ic.:!> ha"e \·alidatcd t.hat MS/MS decrea e the 
numher ot f:Jbe-poo,ith e rt:!!Uit.S lhar can oc-
cur wtlh olc.Jcr mcthud., or t.eo,t.lng . .MS/.\tS at-
lowe; the opportunit) to tdcntifr many new-
horn:-. \\. ith an E.\l prior w car.astrophic in-
'>Uit. , tim!> dccrca.,ing morbtdit) :lnc.l mortal-
It) In .tddit.ion, 1\.IS/MS "iU aJlow improved 
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